Dusseldorf - Delayed Quote EUR
Revenio Group Oyj (R0V.DU)
As of 8:11 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
102,176.00
96,576.00
96,976.00
78,778.00
61,067.00
Cost of Revenue
30,341.00
28,341.00
27,206.00
23,023.00
17,728.00
Gross Profit
71,835.00
68,235.00
69,770.00
55,755.00
43,339.00
Operating Expense
46,493.00
41,893.00
40,088.00
33,025.00
25,238.00
Operating Income
25,342.00
26,342.00
29,682.00
22,730.00
18,101.00
Net Non Operating Interest Income Expense
-443.00
-543.00
-246.00
-251.00
-252.00
Pretax Income
24,484.00
25,384.00
29,056.00
22,099.00
16,719.00
Tax Provision
5,474.00
6,274.00
7,303.00
4,778.00
3,357.00
Net Income Common Stockholders
19,109.00
19,109.00
21,753.00
17,321.00
13,362.00
Diluted NI Available to Com Stockholders
19,109.00
19,109.00
21,753.00
17,321.00
13,362.00
Basic EPS
0.72
0.72
0.82
0.65
0.51
Diluted EPS
0.72
0.72
0.82
0.65
0.50
Basic Average Shares
26,637.14
26,592.77
26,580.37
26,557.46
26,608.03
Diluted Average Shares
26,637.14
26,681.12
26,681.12
26,557.46
26,608.03
Total Operating Income as Reported
25,343.00
26,343.00
29,683.00
22,103.00
17,130.00
Rent Expense Supplemental
--
492.00
449.00
--
277.00
Total Expenses
76,834.00
70,234.00
67,294.00
56,048.00
42,966.00
Net Income from Continuing & Discontinued Operation
19,109.00
19,109.00
21,753.00
17,321.00
13,362.00
Normalized Income
19,109.00
19,109.00
21,753.00
17,813.22
14,137.23
Interest Income
--
220.00
53.00
1.00
1.00
Interest Expense
--
725.00
263.00
223.00
236.00
Net Interest Income
-443.00
-543.00
-246.00
-251.00
-252.00
EBIT
25,109.00
26,109.00
29,319.00
22,322.00
16,955.00
EBITDA
30,253.00
30,053.00
32,753.00
25,942.00
21,518.00
Reconciled Cost of Revenue
30,341.00
28,341.00
27,206.00
23,023.00
17,728.00
Reconciled Depreciation
5,144.00
3,944.00
3,434.00
3,620.00
4,563.00
Net Income from Continuing Operation Net Minority Interest
19,109.00
19,109.00
21,753.00
17,321.00
13,362.00
Total Unusual Items Excluding Goodwill
--
--
--
-628.00
-970.00
Total Unusual Items
--
--
--
-628.00
-970.00
Normalized EBITDA
30,253.00
30,053.00
32,753.00
26,570.00
22,488.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
--
-135.78
-194.77
12/31/2020 - 5/7/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SRBZF Stratec SE
72.96
0.00%
SOMNF SomnoMed Limited
0.1800
0.00%
SNNUF Smith & Nephew plc
12.18
0.00%
RSHUF Respiri Limited
0.0581
0.00%
SUN.L Surgical Innovations Group plc
0.5000
-9.09%
SNZZF Senzime AB (publ)
0.5500
0.00%
PYNKF Perimeter Medical Imaging AI, Inc.
0.4100
0.00%
RPID Rapid Micro Biosystems, Inc.
1.1496
+8.45%
SRDX Surmodics, Inc.
39.07
-0.46%
SNWVD SANUWAVE Health, Inc.
22.00
0.00%